LOGGI, ELISABETTA
LOGGI, ELISABETTA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Adaptive response in Hepatitis B virus infection
2014-01-01 Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P.
Alcoholic liver disease: pathophisiological aspects and risk factors. A review.
2006-01-01 Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M.
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
2009-01-01 Loggi E; Bihl F; Chisolm JV 3rd; Biselli M; Bontadini A; Vitale G; Ercolani G; Grazi GL; Pinna AD; Bernardi M; Brander C; Andreone P.
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C.
2012-01-01 Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M.; Brillanti S.; Andreone P.
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B
2010-01-01 Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C.
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients.
2014-01-01 Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P.
Chronic hepatitis B: Are we close to a cure?
2015-01-01 Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone .
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV.
2012-01-01 Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.; Vandelli C.; Andreone P.; Missale G.; Ferrari C.
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.
2005-01-01 Gramenzi A.; Andreone P.; Loggi E.; Foschi F.G.; Cursaro C.; Margotti M.; Biselli M.; Bernardi M.
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies
2015-01-01 Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects.
2013-01-01 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A.F. Cicero, M. Bernardi, P. Andreone
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
2013-01-01 Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK.
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis.
2005-01-01 Foschi F.G.; Trevisani F.; Loggi E.; Parazza M.; Melotti C.; Bedeschi E.; Mingazzini L.; Mirici Cappa F.; Cescon M.; Andreone P.; Grazi G.; Stefanini G.F.; Bernardi M.
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
2022-01-01 Gallo C.G.; Fiorino S.; Posabella G.; Antonacci D.; Tropeano A.; Pausini E.; Pausini C.; Guarniero T.; Hong W.; Giampieri E.; Corazza I.; Loiacono R.; Loggi E.; de Biase D.; Zippi M.; Lari F.; Zancanaro M.
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS).
2005-01-01 Lorenzini S.; Isidori A.; Loggi E.;Gramenzi A.; Catani L.; Talarico S.; Cursaro C.; Biselli M.; Bonifazi F.; Lemoli RM.; Baccarani M.; Bernardi M.; Andreone P.
Hepatitis B virus and immune response.
2008-01-01 Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Bernardi M; Andreone P.
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
2017-01-01 Loggi, Elisabetta; Gitto, Stefano; Galli, Silvia; Minichiello, Mario; Conti, Fabio; Grandini, Elena; Scuteri, Alessandra; Vitale, Giovanni; Di Donato, Roberto; Cursaro, Carmela; Furlini, Giuliano; Andreone, Pietro*
Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire
2008-01-01 Tan AT; Loggi E; Boni C; Chia A; Gehring AJ; Sastry KS; Goh V; Fisicaro P; Andreone P; Brander C; Lim SG; Ferrari C; Bihl F; Bertoletti A.
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C.
2010-01-01 Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenzi A; Bernardi M; Andreone P.
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
2004-01-01 Andreone P.; Gramenzi A.; Loggi E.; Favarelli L.; Cursaro C.; Margotti M.; Biselli M.; Lorenzini S.; Bernardi M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Adaptive response in Hepatitis B virus infection | Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P. | 2014-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Alcoholic liver disease: pathophisiological aspects and risk factors. A review. | Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M. | 2006-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft | Loggi E; Bihl F; Chisolm JV 3rd; Biselli M; Bontadini A; Vitale G; Ercolani G; Grazi GL; Pinna AD...; Bernardi M; Brander C; Andreone P. | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. | Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M....; Brillanti S.; Andreone P. | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B | Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreo...ne P; Missale G; Ferrari C. | 2010-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. | Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P. | 2014-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Chronic hepatitis B: Are we close to a cure? | Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone . | 2015-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. | Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.;... Vandelli C.; Andreone P.; Missale G.; Ferrari C. | 2012-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. | Gramenzi A.; Andreone P.; Loggi E.; Foschi F.G.; Cursaro C.; Margotti M.; Biselli M.; Bernardi M. | 2005-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies | Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina...; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda | 2015-01-01 | HEPATOLOGY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. | G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A....F. Cicero, M. Bernardi, P. Andreone | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
| Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. | Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; B...ihl F; Andreone P; Maini MK. | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. | Foschi F.G.; Trevisani F.; Loggi E.; Parazza M.; Melotti C.; Bedeschi E.; Mingazzini L.; Mirici C...appa F.; Cescon M.; Andreone P.; Grazi G.; Stefanini G.F.; Bernardi M. | 2005-01-01 | INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection | Gallo C.G.; Fiorino S.; Posabella G.; Antonacci D.; Tropeano A.; Pausini E.; Pausini C.; Guarnier...o T.; Hong W.; Giampieri E.; Corazza I.; Loiacono R.; Loggi E.; de Biase D.; Zippi M.; Lari F.; Zancanaro M. | 2022-01-01 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | - | 1.01 Articolo in rivista | - |
| GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). | Lorenzini S.; Isidori A.; Loggi E.;Gramenzi A.; Catani L.; Talarico S.; Cursaro C.; Biselli M.; B...onifazi F.; Lemoli RM.; Baccarani M.; Bernardi M.; Andreone P. | 2005-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Hepatitis B virus and immune response. | Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Be...rnardi M; Andreone P. | 2008-01-01 | - | Nova Science Publishers Inc | 3.01 Monografia / trattato scientifico in forma di libro | - |
| Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice | Loggi, Elisabetta; Gitto, Stefano; Galli, Silvia; Minichiello, Mario; Conti, Fabio; Grandini, Ele...na; Scuteri, Alessandra; Vitale, Giovanni; Di Donato, Roberto; Cursaro, Carmela; Furlini, Giuliano; Andreone, Pietro* | 2017-01-01 | JOURNAL OF CLINICAL VIROLOGY | - | 1.01 Articolo in rivista | - |
| Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire | Tan AT; Loggi E; Boni C; Chia A; Gehring AJ; Sastry KS; Goh V; Fisicaro P; Andreone P; Brander C;... Lim SG; Ferrari C; Bihl F; Bertoletti A. | 2008-01-01 | JOURNAL OF VIROLOGY | - | 1.01 Articolo in rivista | - |
| Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. | Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenz...i A; Bernardi M; Andreone P. | 2010-01-01 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | - | 1.01 Articolo in rivista | - |
| In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C | Andreone P.; Gramenzi A.; Loggi E.; Favarelli L.; Cursaro C.; Margotti M.; Biselli M.; Lorenzini ...S.; Bernardi M. | 2004-01-01 | CYTOKINE | - | 1.01 Articolo in rivista | - |